FDA Guidance Documents·· 原文未提供具体时分
Recommendations for Dual 510(k) and CLIA Waiver by Application Studies: Guidance for Industry and Food and Drug Administration Staff
Recommendations for Dual 510(k) and CLIA Waiver by Application Studies: Guidance for Industry and Food and Drug Administration Staff
AI 导读
FDA 官方历史目录记录；Final guidance；发布日期：2020-02-26。官方主题：Premarket, Postmarket, CLIA (Clinical Laboratory Improvement Amendments), 510(k)。请通过官方原文与附件查阅文件。
来源：FDA Guidance Documents · fda.gov